RETA - Reata Pharmaceuticals Inc
This page shows which of the focused investors we track hold RETA and how their positions changed, so you can see how much conviction the group has in the stock.
In Q4 2022 it was held by 1 manager with an aggregate reported value of $2.24M, which is 0.00% of the combined portfolio.
As of Q4 2022, 1 tracked institutional manager held RETA (Reata Pharmaceuticals Inc) with an aggregate reported value of $2.24M — 0.00% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades RETA — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q4 2022
- Ticker
- RETA
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Stanley Druckenmiller - Duquesne Family Office LLC | 0.11% | - | 58,997 | $2.24M |
Loading holder history for RETA…